CA Patent

CA2865957C — Compounds for treating spinal muscular atrophy

Assigned to F Hoffmann La Roche AG · Expires 2020-02-11 · 6y expired

What this patent protects

Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy.

USPTO Abstract

Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy.

Drugs covered by this patent

Patent Metadata

Patent number: CA2865957C
Jurisdiction: CA
Classification: —
Expires: 2020-02-11
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.